Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM and Share Capital Reorganisation

24 Sep 2015 12:05

RNS Number : 1073A
AorTech International PLC
24 September 2015
 

 

AorTech International plc

 

(the "Company")

 

Result of AGM and Share Capital Reorganisation

AorTech International plc (AIM: AOR), the biomaterials and medical device IP company, is pleased to announce that at the Annual General Meeting held today, all the resolutions were duly passed.

Accordingly, the proposed share consolidation of the Company's share capital ("Share Capital Reorganisation") will become effective on the record date, being 6.00 p.m. today, 24 September 2015.

Under the Share Capital Reorganisation each of the ordinary shares of 250 pence each in the capital of the Company ("the Existing Ordinary Shares") which at 6pm on 24 September 2015 are shown in the books of the Company to be in issue shall be sub-divided into one new ordinary share of 5 pence in the capital of the Company (each a "New Ordinary Share") and one new deferred share of 245 pence in the capital of the Company (each a "Deferred Share"), such shares having the rights and being subject to the restrictions set out in the Company's articles of association.

 

Application has been made for the 4,832,778 New Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence at 8.00 a.m. on 25 September 2015 with the existing ISIN GB0033360586.

 

Following the Share Capital Reorganisation there will be 4,832,778 New Ordinary Shares in issue. The Company does not hold any shares in treasury. Therefore the total number of shares with voting rights in the Company following Admission will be 4,832,778. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.

 

This information is provided by RNS

For further information contact:

 

AorTech International plc 

Eddie McDaid, Chief Executive Tel: +44 (0)7802 920869

 

AorTech International plc 

Bill Brown, Chairman Tel: +44 (0)7730 718296 

 

finnCap Limited

Jonny Franklin-Adams/ Giles Rolls Tel: +44 20 7220 0500 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGSEEFFLFISESU
Date   Source Headline
17th Feb 20115:06 pmRNSHolding(s) in Company
17th Jan 20117:00 amRNSAorTech Enters Orthopaedic Market
20th Dec 20107:00 amRNSAorTech Announces Interim Results
13th Dec 20107:00 amRNSAortech Announces Human Use of Header Technology
27th Sep 20103:00 pmRNSResult of AGM
9th Sep 20104:49 pmRNSDirector/PDMR Shareholding
24th Aug 20107:00 amRNSAnnual Report and Accounts
2nd Aug 20107:00 amRNSAorTech Announces Year End Preliminary Results
28th Jul 20108:56 amRNSHolding(s) in Company
24th May 20107:00 amRNSAorTech Signs Licensing Agreement
19th May 20107:00 amRNSDirector/PDMR Shareholding
27th Apr 20108:00 amRNSHolding(s) in Company
12th Mar 20104:50 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSAorTech Announces Interim Results
24th Nov 20097:00 amRNSAorTech Receives Record Polymer Order
29th Sep 20097:00 amRNSAnnual Reports and Accounts Posted to Shareholders
21st Sep 20095:06 pmRNSHolding(s) in Company
16th Sep 20095:19 pmRNSResult of AGM
16th Sep 20097:00 amRNSAorTech Signs Licensing Agreement with SynCardia
16th Sep 20097:00 amRNSAorTech AGM Statement
27th Jul 20097:00 amRNSAorTech Issued US Patent for Polymer Heart Valve
22nd Jul 20097:00 amRNSAorTech Announces Final Results
9th Jul 20095:57 pmRNSHolding in Company - correction
19th Jun 200910:53 amRNSHolding(s) in Company
17th Jun 200912:07 pmRNSHolding(s) in Company
15th Jun 20095:13 pmRNSHolding(s) in Company
15th Jun 20095:11 pmRNSHolding(s) in Company
10th Jun 20097:00 amRNSAorTech Signs Licensing Agreement
5th Jun 200912:38 pmRNSHolding(s) in Company
18th May 20097:00 amRNSAorTech Signs Licensing Agreement
5th May 20099:18 amRNSHolding(s) in Company
6th Apr 20097:00 amRNSAorTech International Director/PDMR Shareholding
29th Jan 20097:00 amRNSAorTech Expands Agreement with St. Jude Medical
17th Dec 20087:00 amRNSAorTech Announces Half Yearly Results
8th Dec 20087:00 amRNSAorTech Signs New Licensing Agreement
25th Nov 20087:00 amRNSFDA Approval Granted to Key AorTech Customer
30th Sep 200810:47 amRNSHolding(s) in Company
19th Sep 200810:24 amRNSAnnual Report and Accounts
12th Sep 200812:53 pmRNSHolding(s) in Company
8th Sep 20082:22 pmRNSHolding(s) in Company
27th Aug 20082:50 pmRNSResult of AGM
27th Aug 20087:00 amRNSAGM Statement
26th Aug 200810:00 amRNSAgreement
21st Aug 20087:00 amRNSAorTech Issued Patent for Bio
6th Aug 20087:00 amRNSHolding(s) in Company
4th Aug 20087:00 amRNSAorTech Issued Patent for Pol
28th Jul 20087:00 amRNSSuccess in Animal Trials
23rd Jul 20087:00 amRNS1st Human Use of Cardiac Cann
17th Jun 20087:00 amRNSFinal Results
17th Apr 20085:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.